The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction

Clinical Trial ID NCT03212625

Rank	Title	Journal	Year	PubWeight™‹?›
1	Sorafenib in advanced hepatocellular carcinoma.	N Engl J Med	2008	54.30
2	Management of hepatocellular carcinoma: an update.	Hepatology	2011	33.57
3	Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.	Lancet Oncol	2008	23.93
4	BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.	Cancer Res	2004	21.36
5	Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.	Oncologist	2008	2.22
6	Randomized controlled trial of the prophylactic effect of urea-based cream on sorafenib-associated hand-foot skin reactions in patients with advanced hepatocellular carcinoma.	J Clin Oncol	2015	2.14
7	Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis.	Acta Oncol	2008	1.39
8	Meta-analysis of dermatological toxicities associated with sorafenib.	Clin Exp Dermatol	2011	0.93
9	The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology.	Oncologist	2015	0.92
10	Sorafenib-associated hand-foot syndrome in Japanese patients.	J Dermatol	2010	0.88